Obesity, insulin resistance, dyslipidemia, and hypertension are components of the pathophysiological state known as metabolic syndrome. Adrenergic vasoconstriction is mediated through increases in cytosolic Ca 2ϩ and the myofilaments' sensitivity to Ca 2ϩ . In many pathophysiological states, there is an enhanced role for Rho kinase (ROK)-mediated increases in Ca 2ϩ sensitivity of the contractile apparatus. Thus we hypothesized that there is a greater role for ROK-mediated increases in Ca 2ϩ sensitivity in ␣1-adrenergic vasoconstriction in arteries from obese Zucker (OZ) rats. Therefore, small gracilis muscle arteries from 11-to 12-wk-old and 16-to 18-wk-old lean and OZ rats were isolated, cannulated, and pressurized to 75 mmHg. For some experiments, vessels were loaded with fura 2-AM. Changes in luminal diameter and vessel wall Ca 2ϩ concentration ([Ca 2ϩ ]) were measured in response to phenylephrine (PE), the thromboxane mimetic U-46619, and KCl. ␣1-Adrenergic vasoconstriction was similar between 11-to 12-wk-old lean and obese animals and greater in older obese animals compared with controls. PE-induced increases in vascular smooth muscle cell [Ca 2ϩ ] were blunted in OZ animals compared with lean controls in both age groups of animals. KCl and U-46619 elicited similar vasoconstriction and vascular smooth muscle cell [Ca 2ϩ ] in both groups. ROK inhibition attenuated PE vasoconstriction to a greater degree in arteries from 11-to 12-wk-old OZ rats compared with lean animals; ROK inhibition in arteries from older rats right shifted both concentration-response curves to the same point. Total RhoA and ROK␣ protein expressions were similar between groups. These results suggest an enhanced role for the ROK pathway in ␣1-adrenergic vasoconstriction in metabolic syndrome. vascular smooth muscle; vascular reactivity; isolated vessel; fura 2; phenylephrine; Type 2 diabetes METABOLIC SYNDROME IS A COHORT of pathophysiological conditions that include obesity, insulin resistance, dyslipidemia, and hypertension. Epidemiological reports suggest that ϳ24% of adults in the United States over 20 yr of age meet the criteria for metabolic syndrome established by the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults III (15). On the basis of year 2000 census data, ϳ47 million Americans have metabolic syndrome (16). Metabolic syndrome has been shown to be associated with alterations in vascular reactivity. Indeed, blunted endothelial-dependent vasodilation and augmented vasoconstriction have been demonstrated in both obese humans (3,14,26,43,47) and animals (10, 17-20, 30, 34, 37, 51 (11,24,27,36). MLCP consists of a 37-to 38-kDa catalytic subunit (PP1c), an associated 110-to 130-kDa targeting subunit (MYPT1), and a third 20-kDa subunit of unknown function. Phosphorylation of the MYPT1 subunit of MLCP inhibits its activity, increasing the Ca 2ϩ sensitivity of the contractile apparatus for a given [Ca 2ϩ ]. It is well established that MLCP can be i...